SLC7A11 and cancer: Myc is known to upregulate xCT expression [7,8]; at the same time, xCT also regulates Myc expression by increasing intracellular glutamate levels, which enhances Myc’s transcriptional activity [9,10], promoting both survival and drug resistance in cancer cells.